|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.260 EUR | -1.81% |
|
-1.95% | +52.34% |
| 06-23 | THX Pharma appoints Sophie Jacq Lapointe to its board of directors |  |
| 06-22 | THX Pharma Announces Appointment of Sophie Jacq Lapointe to Board of Directors | CI |
| Market Cap | 45.8M 52.33M 42.28M 39.44M 74.31M 4.95B 75.64M 507M 197M 2.44B 197M 192M 8.51B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 22.1M 25.25M 20.4M 19.03M 35.86M 2.39B 36.5M 245M 95.02M 1.18B 94.88M 92.76M 4.1B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.97% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.81% | ||
| 1 week | -1.95% | ||
| Current month | -1.81% | ||
| 1 month | -8.17% | ||
| 3 months | +3.49% | ||
| 6 months | +43.61% | ||
| Current year | +52.34% |
| 1 week | 3.12 |  | 3.46 |
| 1 month | 3.04 | | 4.1 |
| Current year | 1.83 | | 5.1 |
| 1 year | 0.98 | | 5.1 |
| 3 years | 0.26 | | 5.1 |
| 5 years | 0.26 | | 10.88 |
| 10 years | 0.26 | | 23.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | - | 2022-12-31 | |
Christine Placet
DFI | Director of Finance/CFO | - | 2024-03-31 |
Marie Sebille
CTO | Chief Tech/Sci/R&D Officer | - | 2021-10-18 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 2024-03-30 | |
| Chairman | - | 2024-03-30 | |
Julien Veys
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 04-02 | Buy | Chief Operating Officer | 4,944 | 0.0342% | ||
| 04-02 | Buy | Chief Operating Officer | 4,488 | 0.0310% | ||
| 04-02 | Buy | Chief Operating Officer | 2,825 | 0.0195% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.81% | -1.95% | +210.48% | +86.29% | 52.33M | |
| +0.27% | +8.63% | +71.02% | +132.74% | 57.65B | |
| -1.32% | +17.12% | +79.02% | +99.82% | 55.14B | |
| -1.28% | +2.68% | -12.60% | -13.79% | 23.53B | |
| +1.79% | +4.38% | +5.94% | +405.31% | 23.11B | |
| -1.93% | +11.11% | +34.89% | -7.86% | 18.14B | |
| +1.28% | +6.54% | +38.27% | -29.91% | 16.84B | |
| +0.24% | +5.98% | +23.45% | +184.72% | 13.68B | |
| +0.14% | +9.60% | +33.31% | - | 12.97B | |
| +1.83% | +4.58% | +77.42% | +132.45% | 12.38B | |
| Average | -0.10% | +5.11% | +56.12% | +109.97% | 23.35B | |
| Weighted average by Cap. | -0.16% | +4.87% | +48.36% | +116.65% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 11.9M 13.6M 10.99M 10.25M 19.31M 1.29B 19.65M 132M 51.16M 634M 51.08M 49.94M 2.21B | 4.3M 4.91M 3.97M 3.7M 6.98M 464M 7.1M 47.61M 18.48M 229M 18.46M 18.04M 799M |
| Net Debt | -23.7M -27.08M -21.88M -20.41M -38.45M -2.56B -39.14M -262M -102M -1.26B -102M -99.45M -4.4B | -27.4M -31.3M -25.29M -23.59M -44.45M -2.96B -45.25M -303M -118M -1.46B -118M -115M -5.09B |
Employees
12
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-01 | €3.260 | -1.81% | 20,476 |
| 26-06-30 | €3.320 | -0.90% | 35,246 |
| 26-06-29 | €3.350 | +6.35% | 45,464 |
| 26-06-26 | €3.150 | -1.25% | 75,503 |
| 26-06-25 | €3.190 | -4.06% | 77,589 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
3.320EUR
Average target price
5.800EUR
Spread / Average Target
+74.70%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ALTHX Stock
Select your edition
All financial news and data tailored to specific country editions
